{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T21:12:05Z","timestamp":1791234725380,"version":"4.1.0"},"reference-count":47,"publisher":"Spandidos Publications","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.3892\/ijo.2016.3362","type":"journal-article","created":{"date-parts":[[2016,1,29]],"date-time":"2016-01-29T09:13:43Z","timestamp":1454058823000},"page":"1581-1589","source":"Crossref","is-referenced-by-count":40,"title":["Placenta growth factor and neuropilin-1 collaborate in promoting melanoma aggressiveness"],"prefix":"10.3892","volume":"48","author":[{"given":"ELENA","family":"PAGANI","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"FEDERICA","family":"RUFFINI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"GIAN CARLO ANTONINI","family":"CAPPELLINI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ALESSANDRO","family":"SCOPPOLA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"CRISTINA","family":"FORTES","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"PAOLO","family":"MARCHETTI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"GRAZIA","family":"GRAZIANI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"STEFANIA","family":"D'ATRI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"PEDRO MIGUEL","family":"LACAL","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2016,1,29]]},"reference":[{"key":"key20180107185206_b1-ijo-48-04-1581","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1038\/nrc2524","article-title":"FLT1 and its ligands VEGFB and PlGF: drug targets for anti-angiogenic therapy?","volume":"8","author":"Fischer","year":"2008","journal-title":"Nat Rev Cancer"},{"key":"key20180107185206_b2-ijo-48-04-1581","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.bbrc.2008.07.121","article-title":"VEGF receptor protein-tyrosine kinases: structure and regulation","volume":"375","author":"Roskoski","year":"2008","journal-title":"Biochem Biophys Res Commun"},{"key":"key20180107185206_b3-ijo-48-04-1581","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.ceb.2008.12.012","article-title":"VEGFs and receptors involved in angiogenesis versus lymphangiogenesis","volume":"21","author":"Lohela","year":"2009","journal-title":"Curr Opin Cell Biol"},{"key":"key20180107185206_b4-ijo-48-04-1581","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1517\/14728222.2014.948420","article-title":"Placental growth factor in cancer","volume":"18","author":"Dewerchin","year":"2014","journal-title":"Expert Opin Ther Targets"},{"key":"key20180107185206_b5-ijo-48-04-1581","doi-asserted-by":"crossref","first-page":"10","DOI":"10.3858\/emm.2012.44.1.023","article-title":"Role of placenta growth factor in cancer and inflammation","volume":"44","author":"Kim","year":"2012","journal-title":"Exp Mol Med"},{"key":"key20180107185206_b6-ijo-48-04-1581","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1038\/nm884","article-title":"Role of PlGF in the intra- and intermolecular cross talk between the VEGF receptors Flt1 and Flk1","volume":"9","author":"Autiero","year":"2003","journal-title":"Nat Med"},{"key":"key20180107185206_b7-ijo-48-04-1581","doi-asserted-by":"crossref","first-page":"643","DOI":"10.2353\/ajpath.2006.051041","article-title":"Increased melanoma growth and metastasis spreading in mice overexpressing placenta growth factor","volume":"169","author":"Marcellini","year":"2006","journal-title":"Am J Pathol"},{"key":"key20180107185206_b8-ijo-48-04-1581","first-page":"241","article-title":"Placenta growth factor induces melanoma resistance to temozolomide through a mechanism that involves the activation of the transcription factor NF-\u03baB","volume":"38","author":"Levati","year":"2011","journal-title":"Int J Oncol"},{"issue":"Suppl","key":"key20180107185206_b9-ijo-48-04-1581","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1002\/cncr.24789","article-title":"Vascular endothelial growth factor receptor-1 in human cancer: concise review and rationale for development of IMC-18F1 (Human antibody targeting vascular endothelial growth factor receptor-1)","volume":"116","author":"Schwartz","year":"2010","journal-title":"Cancer"},{"key":"key20180107185206_b10-ijo-48-04-1581","first-page":"2749","article-title":"Placental growth factor is a survival factor for tumor endothelial cells and macrophages","volume":"62","author":"Adini","year":"2002","journal-title":"Cancer Res"},{"key":"key20180107185206_b11-ijo-48-04-1581","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/S0012-1606(03)00449-4","article-title":"Human cytotrophoblasts promote endothelial survival and vascular remodeling through secretion of Ang2, PlGF, and VEGF-C","volume":"263","author":"Zhou","year":"2003","journal-title":"Dev Biol"},{"key":"key20180107185206_b12-ijo-48-04-1581","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1002\/ijc.21865","article-title":"The vascular endothelial growth factor receptor (VEGFR-1) supports growth and survival of human breast carcinoma","volume":"119","author":"Wu","year":"2006","journal-title":"Int J Cancer"},{"key":"key20180107185206_b13-ijo-48-04-1581","doi-asserted-by":"crossref","first-page":"6573","DOI":"10.1158\/1078-0432.CCR-06-0831","article-title":"Anti-vascular endothelial growth factor receptor-1 antagonist antibody as a therapeutic agent for cancer","volume":"12","author":"Wu","year":"2006","journal-title":"Clin Cancer Res"},{"key":"key20180107185206_b14-ijo-48-04-1581","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1182\/blood-2005-06-2530","article-title":"VEGFR-1 (FLT-1) activation modulates acute lymphoblastic leukemia localization and survival within the bone marrow, determining the onset of extramedullary disease","volume":"107","author":"Fragoso","year":"2006","journal-title":"Blood"},{"key":"key20180107185206_b15-ijo-48-04-1581","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1046\/j.1523-1747.2000.00199.x","article-title":"Human melanoma cells secrete and respond to placenta growth factor and vascular endothelial growth factor","volume":"115","author":"Lacal","year":"2000","journal-title":"J Invest Dermatol"},{"key":"key20180107185206_b16-ijo-48-04-1581","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1111\/j.0022-202X.2004.23460.x","article-title":"Overproduction of VEGF concomitantly expressed with its receptors promotes growth and survival of melanoma cells through MAPK and PI3K signaling","volume":"123","author":"Graells","year":"2004","journal-title":"J Invest Dermatol"},{"key":"key20180107185206_b17-ijo-48-04-1581","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1007\/s004320050325","article-title":"Melanoma-associated expression of vascular endothelial growth factor and its receptors FLT-1 and KDR","volume":"125","author":"Graeven","year":"1999","journal-title":"J Cancer Res Clin Oncol"},{"key":"key20180107185206_b18-ijo-48-04-1581","first-page":"1625","article-title":"An autocrine loop directed by the vascular endothelial growth factor promotes invasiveness of human melanoma cells","volume":"27","author":"Lacal","year":"2005","journal-title":"Int J Oncol"},{"key":"key20180107185206_b19-ijo-48-04-1581","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.bbapap.2009.09.002","article-title":"Structure-function analysis of VEGF receptor activation and the role of coreceptors in angiogenic signaling","volume":"1804","author":"Gr\u00fcnewald","year":"2010","journal-title":"Biochim Biophys Acta"},{"key":"key20180107185206_b20-ijo-48-04-1581","doi-asserted-by":"crossref","first-page":"9904","DOI":"10.1074\/jbc.M412017200","article-title":"Vascular endothelial growth factor (VEGF)-A165-induced prostacyclin synthesis requires the activation of VEGF receptor-1 and -2 heterodimer","volume":"280","author":"Neagoe","year":"2005","journal-title":"J Biol Chem"},{"key":"key20180107185206_b21-ijo-48-04-1581","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.cellsig.2011.09.003","article-title":"Neuropilin-1 regulates a new VEGF-induced gene, Phactr-1, which controls tubulogenesis and modulates lamel-lipodial dynamics in human endothelial cells","volume":"24","author":"Allain","year":"2012","journal-title":"Cell Signal"},{"key":"key20180107185206_b22-ijo-48-04-1581","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.devcel.2006.03.012","article-title":"Selective regulation of arterial branching morphogenesis by synectin","volume":"10","author":"Chittenden","year":"2006","journal-title":"Dev Cell"},{"key":"key20180107185206_b23-ijo-48-04-1581","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1016\/j.cell.2013.01.036","article-title":"Targeting placental growth factor\/neuropilin 1 pathway inhibits growth and spread of medulloblastoma","volume":"152","author":"Snuderl","year":"2013","journal-title":"Cell"},{"key":"key20180107185206_b24-ijo-48-04-1581","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1158\/1535-7163.MCT-05-0538","article-title":"The role of neuropilins in cancer","volume":"5","author":"Ellis","year":"2006","journal-title":"Mol Cancer Ther"},{"key":"key20180107185206_b25-ijo-48-04-1581","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1016\/j.cellsig.2007.05.013","article-title":"Vascular endothelial growth factor receptor-2: structure, function, intra-cellular signalling and therapeutic inhibition","volume":"19","author":"Holmes","year":"2007","journal-title":"Cell Signal"},{"key":"key20180107185206_b26-ijo-48-04-1581","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1124\/pr.114.010215","article-title":"The great escape; the hallmarks of resistance to antiangiogenic therapy","volume":"67","author":"van Beijnum","year":"2015","journal-title":"Pharmacol Rev"},{"key":"key20180107185206_b27-ijo-48-04-1581","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1200\/JCO.2012.46.2762","article-title":"Markers of response for the antiangiogenic agent bevacizumab","volume":"31","author":"Lambrechts","year":"2013","journal-title":"J Clin Oncol"},{"key":"key20180107185206_b28-ijo-48-04-1581","doi-asserted-by":"crossref","first-page":"297","DOI":"10.3892\/ijo.2013.1948","article-title":"Neuropilin-1 expression promotes invasiveness of melanoma cells through vascular endothelial growth factor receptor-2-dependent and -independent mechanisms","volume":"43","author":"Ruffini","year":"2013","journal-title":"Int J Oncol"},{"key":"key20180107185206_b29-ijo-48-04-1581","doi-asserted-by":"crossref","first-page":"E545","DOI":"10.1002\/ijc.29252","article-title":"Cilengitide downmodulates invasiveness and vasculogenic mimicry of neuropilin 1 expressing melanoma cells through the inhibition of \u03b1v\u03b25 integrin","volume":"136","author":"Ruffini","year":"2015","journal-title":"Int J Cancer"},{"key":"key20180107185206_b30-ijo-48-04-1581","doi-asserted-by":"crossref","first-page":"3479","DOI":"10.1242\/jcs.00673","article-title":"Vascular endothelial growth factor receptor-1 is deposited in the extracellular matrix by endothelial cells and is a ligand for the alpha 5 beta 1 integrin","volume":"116","author":"Orecchia","year":"2003","journal-title":"J Cell Sci"},{"key":"key20180107185206_b31-ijo-48-04-1581","doi-asserted-by":"crossref","first-page":"2887","DOI":"10.3892\/or.2013.2791","article-title":"Platelet-derived growth factor C and calpain-3 are modulators of human melanoma cell invasiveness","volume":"30","author":"Ruffini","year":"2013","journal-title":"Oncol Rep"},{"key":"key20180107185206_b32-ijo-48-04-1581","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/j.ajpath.2012.07.013","article-title":"Tumor cell vasculogenic mimicry: From controversy to therapeutic promise","volume":"181","author":"Seftor","year":"2012","journal-title":"Am J Pathol"},{"key":"key20180107185206_b33-ijo-48-04-1581","first-page":"537","article-title":"PGF isoforms, PLGF-1 and PGF-2 and the PGF receptor, neuropilin, in human breast cancer: prognostic significance","volume":"23","author":"Escudero-Esparza","year":"2010","journal-title":"Oncol Rep"},{"key":"key20180107185206_b34-ijo-48-04-1581","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1002\/mc.20248","article-title":"Breast cancer cells secreted platelet-derived growth factor-induced motility of vascular smooth muscle cells is mediated through neuropilin-1","volume":"45","author":"Banerjee","year":"2006","journal-title":"Mol Carcinog"},{"key":"key20180107185206_b35-ijo-48-04-1581","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1186\/1476-4598-9-209","article-title":"Tumor cell-derived PDGF-B potentiates mouse mesenchymal stem cells-pericytes transition and recruitment through an interaction with NRP-1","volume":"9","author":"Dhar","year":"2010","journal-title":"Mol Cancer"},{"key":"key20180107185206_b36-ijo-48-04-1581","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1042\/BJ20100580","article-title":"Neuropilin-1 mediates PDGF stimulation of vascular smooth muscle cell migration and signalling via p130Cas","volume":"435","author":"Pellet-Many","year":"2011","journal-title":"Biochem J"},{"key":"key20180107185206_b37-ijo-48-04-1581","doi-asserted-by":"crossref","first-page":"773","DOI":"10.2174\/187152012802650228","article-title":"Regulation of MMPs during melanoma progression: from genetic to epigenetic","volume":"12","author":"Frank","year":"2012","journal-title":"Anticancer Agents Med Chem"},{"key":"key20180107185206_b38-ijo-48-04-1581","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1007\/s12032-013-0676-7","article-title":"Phase2 study of bevacizumab with carboplatin-paclitaxel for non-small cell lung cancer with malignant pleural effusion","volume":"30","author":"Tamiya","year":"2013","journal-title":"Med Oncol"},{"key":"key20180107185206_b39-ijo-48-04-1581","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1186\/s12885-015-1130-3","article-title":"Cell type- and tumor zone-specific expression of pVEGFR-1 and its ligands influence colon cancer metastasis","volume":"15","author":"Jayasinghe","year":"2015","journal-title":"BMC Cancer"},{"key":"key20180107185206_b40-ijo-48-04-1581","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1158\/1078-0432.CCR-10-2687","article-title":"Placental growth factor upregulation is a host response to antiangiogenic therapy","volume":"17","author":"Bagley","year":"2011","journal-title":"Clin Cancer Res"},{"key":"key20180107185206_b41-ijo-48-04-1581","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.cell.2007.08.038","article-title":"Anti-PlGF inhibits growth of VEGF(R)-inhibitor-resistant tumors without affecting healthy vessels","volume":"131","author":"Fischer","year":"2007","journal-title":"Cell"},{"key":"key20180107185206_b42-ijo-48-04-1581","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/j.jmb.2006.11.021","article-title":"Function blocking antibodies to neuropilin-1 generated from a designed human synthetic antibody phage library","volume":"366","author":"Liang","year":"2007","journal-title":"J Mol Biol"},{"key":"key20180107185206_b43-ijo-48-04-1581","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.ccr.2006.10.018","article-title":"Blocking neuropilin-1 function has an additive effect with anti-VEGF to inhibit tumor growth","volume":"11","author":"Pan","year":"2007","journal-title":"Cancer Cell"},{"key":"key20180107185206_b44-ijo-48-04-1581","doi-asserted-by":"crossref","first-page":"6040","DOI":"10.1158\/1078-0432.CCR-12-1652","article-title":"Pharmacokinetic and pharmacodynamic analysis of circulating biomarkers of anti-NRP1, a novel antiangiogenesis agent, in two phase I trials in patients with advanced solid tumors","volume":"18","author":"Xin","year":"2012","journal-title":"Clin Cancer Res"},{"key":"key20180107185206_b45-ijo-48-04-1581","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/sj.bjc.6605539","article-title":"Neuropilin-1 antagonism in human carcinoma cells inhibits migration and enhances chemosensitivity","volume":"102","author":"Jia","year":"2010","journal-title":"Br J Cancer"},{"key":"key20180107185206_b46-ijo-48-04-1581","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1097\/CAD.0000000000000091","article-title":"A monoclonal antibody targeting neuropilin-1 inhibits adhesion of MCF7 breast cancer cells to fibronectin by suppressing the FAK\/p130cas signaling pathway","volume":"25","author":"Zeng","year":"2014","journal-title":"Anticancer Drugs"},{"key":"key20180107185206_b47-ijo-48-04-1581","doi-asserted-by":"crossref","first-page":"125","DOI":"10.3389\/fonc.2015.00125","article-title":"Neuropilin-1 as therapeutic target for malignant melanoma","volume":"5","author":"Graziani","year":"2015","journal-title":"Front Oncol"}],"container-title":["International Journal of Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/ijo.2016.3362\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,2]],"date-time":"2022-06-02T19:06:27Z","timestamp":1654196787000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/ijo.2016.3362"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1,29]]},"references-count":47,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2016,1,29]]},"published-print":{"date-parts":[[2016,4]]}},"alternative-id":["10.3892\/ijo.2016.3362"],"URL":"https:\/\/doi.org\/10.3892\/ijo.2016.3362","relation":{},"ISSN":["1019-6439","1791-2423"],"issn-type":[{"value":"1019-6439","type":"print"},{"value":"1791-2423","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,1,29]]}}}